Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FAMWA, FTOS

Ozempic and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid and alcohol use disorders, a new study showed.

Over half of patients who stopped taking liraglutide or semaglutide were able to maintain their weight for a year, according to a recent study from Epic Research.

An FDA investigation of popular weight-loss drugs has generated a storm of media attention and prompted patient questions.

Eli Lilly and Co. released an open letter stating its tirzepatide products should not be used for cosmetic weight loss and warning the public about the circulation of compounded and counterfeit tirzepatide.

Eating disorder claims in the United States rose 65% as a percentage of all medical claims over the last 5 years, according to a report from FAIR Health, a health care claims repository.

DALLAS — In this Healio video exclusive, Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS, discusses cultural competency with regard to obesity care.

Adhering to a healthy lifestyle could reduce coronary heart disease risk regardless of genetic susceptibility to abdominal obesity, according to the results of research published in the American Journal of Clinical Nutrition.

DANA POINT, Calif. — In this Healio video exclusive, Fatima Cody Stanford, MD, MPA, MPH, MBA, discusses considerations clinicians must make regarding women with obesity.

The AMA House of Delegates adopted a new policy encouraging physicians to use BMI in conjunction with other valid measures when assessing patients for overweight or obesity.

The concept of food addiction is a hotly debated one.